Indivior Pharmaceuticals, Inc. (DELISTED) (INDV:DL)
36.28
+0.91
(+2.57%)
USD |
NASDAQ |
Nov 02, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.281B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 23.53% |
| Valuation | |
| PE Ratio | 10.04 |
| PE Ratio (Forward) | |
| PS Ratio | 3.301 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 8.13 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -8.35 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 96.00% |
Profile
| Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA. |
| URL | http://www.indivior.com |
| Investor Relations URL | N/A |
| HQ State/Province | Virginia |
| Sector | |
| Industry | |
| Equity Style | Small Cap Core |
| Next Earnings Release | Feb. 25, 2027 (est.) |
| Last Earnings Release | Oct. 29, 2026 |
| Next Ex-Dividend Date | Nov. 03, 2026 |
| Last Ex-Dividend Date | Nov. 03, 2026 |
Profile
| Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA. |
| URL | http://www.indivior.com |
| Investor Relations URL | N/A |
| HQ State/Province | Virginia |
| Sector | |
| Industry | |
| Equity Style | Small Cap Core |
| Next Earnings Release | Feb. 25, 2027 (est.) |
| Last Earnings Release | Oct. 29, 2026 |
| Next Ex-Dividend Date | Nov. 03, 2026 |
| Last Ex-Dividend Date | Nov. 03, 2026 |